WWA
EW icon

Wealth Watch Advisors’s Edwards Lifesciences EW Stock Holding History

Wealth Watch Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17
Closed -$1.45K – 368
2025
Q4 		$1.45K Hold
17
– – ﹤0.01% 723
2025
Q3 		$1.32K Buy
+17
New +$1.33K ﹤0.01% 718

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wealth Watch Advisors's EW Position: Q1 2026 in Review

Wealth Watch Advisors sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 17 shares — an estimated $1.45K sold.

Wealth Watch Advisors first reported a position in EW in Q3 2025 and held it in 2 quarters. The position peaked at $1.45K in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Wealth Watch Advisors reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • Wealth Watch Advisors sold 17 Edwards Lifesciences shares in Q1 2026, an estimated $1.45K.
  • Wealth Watch Advisors first reported a position in Edwards Lifesciences in Q3 2025 and held it in 2 quarters.
  • Wealth Watch Advisors's Edwards Lifesciences position peaked at $1.45K in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Wealth Watch Advisors's 13F filing for Q1 2026, filed 15 May 2026.